speb/financial-data huggingface dataset:
BCAB income_statement (quarterly, 2025-09-30) — Net Income: -15778000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -15778000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -15778000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -15778000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -15778000.00
BCAB cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -15778000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -15778000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Interest Income: 133000.00
BCAB income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 133000.00
BCAB cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -6000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Net PPE: 6075000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -31237000.00
BCAB income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -11614000.00
BCAB income_statement (quarterly, 2025-09-30) — Normalized Income: -13659000.00
BCAB cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -9881000.00
BCAB cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2119000.00
BCAB income_statement (quarterly, 2025-09-30) — Operating Income: -13789000.00
BCAB income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BCAB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1175841.00
BCAB balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 185000.00
BCAB income_statement (quarterly, 2025-09-30) — Other Gand A: 4250000.00
BCAB income_statement (quarterly, 2025-09-30) — Other Income Expense: -2122000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 163000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 19806000.00
BCAB income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -3000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Other Properties: 8031000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Payables: 5851000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 14389000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 2422000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BCAB balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1165000.00
BCAB income_statement (quarterly, 2025-09-30) — Pretax Income: -15778000.00
BCAB cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
BCAB balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
BCAB income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 56000.00
BCAB income_statement (quarterly, 2025-09-30) — Research And Development: 9539000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -535862000.00
BCAB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4250000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Share Issued: 1175841.00
BCAB cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1292000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -31237000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -31237000.00
BCAB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BCAB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Assets: 15908000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -31237000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Debt: 6181000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -31237000.00
BCAB income_statement (quarterly, 2025-09-30) — Total Expenses: 13789000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 47145000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 6238000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 29161000.00
BCAB income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -13789000.00
BCAB income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2119000.00
BCAB income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2119000.00
BCAB balance_sheet (quarterly, 2025-09-30) — Working Capital: -8314000.00
BCAB income_statement (annual, 2025-12-31) — +Operating Expense: 61305000.00
BCAB income_statement (quarterly, 2025-12-31) — +Operating Expense: 11255000.00
BCAB income_statement (annual, 2025-12-31) — +Total Revenue: 2000000.00
BCAB income_statement (quarterly, 2025-12-31) — +Total Revenue: 2000000.00
BCAB balance_sheet (annual, 2025-12-31) — Accounts Payable: 8194000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8194000.00
BCAB balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -5308000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -5308000.00
BCAB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 509451000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 509451000.00
BCAB income_statement (annual, 2025-12-31) — Basic Average Shares: 1176558.00
BCAB income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1195933.00
BCAB income_statement (annual, 2025-12-31) — Basic EPS: -50.50
BCAB income_statement (quarterly, 2025-12-31) — Basic EPS: -8.00
BCAB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 49046000.00
BCAB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8320000.00
BCAB balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6200000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6200000.00
BCAB balance_sheet (annual, 2025-12-31) — Capital Stock: 6000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6000.00
BCAB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 7118000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 7118000.00
BCAB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7118000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7118000.00
BCAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 6276000.00
BCAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 6713000.00
BCAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -48204000.00
BCAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -7915000.00
BCAB cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 344000.00
BCAB cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 238000.00
BCAB cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2804000.00
BCAB cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -747000.00
BCAB cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1128000.00
BCAB cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 455000.00
BCAB cash_flow (annual, 2025-12-31) — Change In Working Capital: 4276000.00
BCAB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -54000.00
BCAB cash_flow (annual, 2025-12-31) — Changes In Cash: -41928000.00
BCAB cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1202000.00
BCAB balance_sheet (annual, 2025-12-31) — Common Stock: 6000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Common Stock: 6000.00
BCAB balance_sheet (annual, 2025-12-31) — Common Stock Equity: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -36189000.00
BCAB cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
BCAB balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 8122000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8122000.00
BCAB balance_sheet (annual, 2025-12-31) — Current Assets: 8013000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Current Assets: 8013000.00
BCAB balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1427000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1427000.00
BCAB balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1427000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1427000.00
BCAB balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 4142000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 4142000.00
BCAB balance_sheet (annual, 2025-12-31) — Current Liabilities: 21922000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 21922000.00
BCAB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 373000.00
BCAB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 19000.00
BCAB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 373000.00
BCAB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 19000.00
BCAB balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 3516000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 3516000.00
BCAB income_statement (annual, 2025-12-31) — Diluted Average Shares: 1176558.00
BCAB income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1195933.00
BCAB income_statement (annual, 2025-12-31) — Diluted EPS: -50.50
BCAB income_statement (quarterly, 2025-12-31) — Diluted EPS: -8.00
BCAB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -9784000.00
BCAB income_statement (annual, 2025-12-31) — EBIT: -59305000.00
BCAB income_statement (quarterly, 2025-12-31) — EBIT: -9255000.00
BCAB income_statement (annual, 2025-12-31) — EBITDA: -58932000.00
BCAB income_statement (quarterly, 2025-12-31) — EBITDA: -9236000.00
BCAB cash_flow (annual, 2025-12-31) — End Cash Position: 7118000.00
BCAB cash_flow (quarterly, 2025-12-31) — End Cash Position: 7118000.00
BCAB cash_flow (annual, 2025-12-31) — Financing Cash Flow: 6276000.00
BCAB cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 6713000.00
BCAB cash_flow (annual, 2025-12-31) — Free Cash Flow: -48204000.00
BCAB cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -7915000.00
BCAB cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -295000.00
BCAB cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -831000.00
BCAB cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 185000.00
BCAB income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 295000.00
BCAB income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 831000.00
BCAB income_statement (annual, 2025-12-31) — General And Administrative Expense: 17732000.00
BCAB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3260000.00
BCAB balance_sheet (annual, 2025-12-31) — Gross PPE: 10960000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Gross PPE: 10960000.00
BCAB income_statement (annual, 2025-12-31) — Interest Income: 843000.00
BCAB income_statement (quarterly, 2025-12-31) — Interest Income: 73000.00
BCAB income_statement (annual, 2025-12-31) — Interest Income Non Operating: 843000.00
BCAB income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 73000.00
BCAB balance_sheet (annual, 2025-12-31) — Invested Capital: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Invested Capital: -36189000.00
BCAB cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
BCAB cash_flow (annual, 2025-12-31) — Issuance Of Debt: 7125000.00
BCAB balance_sheet (annual, 2025-12-31) — Leases: 2498000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Leases: 2498000.00
BCAB balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4773000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4773000.00
BCAB balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4773000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4773000.00
BCAB cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 7125000.00
BCAB balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1101000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1101000.00
BCAB cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
BCAB income_statement (annual, 2025-12-31) — Net Income: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Income: -9784000.00
BCAB income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -9784000.00
BCAB income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -9784000.00
BCAB income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9784000.00
BCAB income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9784000.00
BCAB cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -59607000.00
BCAB cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -9784000.00
BCAB income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -9784000.00
BCAB income_statement (annual, 2025-12-31) — Net Interest Income: 843000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Interest Income: 73000.00
BCAB cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 7125000.00
BCAB cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 7125000.00
BCAB income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 843000.00
BCAB income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 73000.00
BCAB cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -949000.00
BCAB cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -465000.00
BCAB balance_sheet (annual, 2025-12-31) — Net PPE: 5652000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Net PPE: 5652000.00
BCAB balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -36189000.00
BCAB income_statement (annual, 2025-12-31) — Normalized EBITDA: -59227000.00
BCAB income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -10067000.00
BCAB income_statement (annual, 2025-12-31) — Normalized Income: -59902000.00
BCAB income_statement (quarterly, 2025-12-31) — Normalized Income: -10615000.00
BCAB cash_flow (annual, 2025-12-31) — Operating Cash Flow: -48204000.00
BCAB cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -7915000.00
BCAB cash_flow (annual, 2025-12-31) — Operating Gains Losses: -110000.00
BCAB cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -646000.00
BCAB income_statement (annual, 2025-12-31) — Operating Income: -59305000.00
BCAB income_statement (quarterly, 2025-12-31) — Operating Income: -9255000.00
BCAB income_statement (annual, 2025-12-31) — Operating Revenue: 2000000.00
BCAB income_statement (quarterly, 2025-12-31) — Operating Revenue: 2000000.00
BCAB balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1269286.00
BCAB balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1269286.00
BCAB balance_sheet (annual, 2025-12-31) — Other Current Assets: 232000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 232000.00
BCAB income_statement (annual, 2025-12-31) — Other Gand A: 17732000.00
BCAB income_statement (quarterly, 2025-12-31) — Other Gand A: 3260000.00
BCAB income_statement (annual, 2025-12-31) — Other Income Expense: -1145000.00
BCAB income_statement (quarterly, 2025-12-31) — Other Income Expense: -602000.00
BCAB cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1024000.00
BCAB balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 163000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 163000.00
BCAB balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 19806000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 19806000.00
BCAB income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1440000.00
BCAB income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1433000.00
BCAB balance_sheet (annual, 2025-12-31) — Other Properties: 7361000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Other Properties: 7361000.00
BCAB balance_sheet (annual, 2025-12-31) — Payables: 8194000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Payables: 8194000.00
BCAB balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 16316000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 16316000.00
BCAB balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37000.00
BCAB balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BCAB balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BCAB balance_sheet (annual, 2025-12-31) — Prepaid Assets: 663000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 663000.00
BCAB income_statement (annual, 2025-12-31) — Pretax Income: -59607000.00
BCAB income_statement (quarterly, 2025-12-31) — Pretax Income: -9784000.00
BCAB cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 100000.00
BCAB cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 53000.00
BCAB balance_sheet (annual, 2025-12-31) — Properties: 0.00
BCAB balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BCAB income_statement (annual, 2025-12-31) — Reconciled Depreciation: 373000.00
BCAB income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 19000.00
BCAB income_statement (annual, 2025-12-31) — Research And Development: 43573000.00
BCAB income_statement (quarterly, 2025-12-31) — Research And Development: 7995000.00
BCAB balance_sheet (annual, 2025-12-31) — Retained Earnings: -545646000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -545646000.00
BCAB income_statement (annual, 2025-12-31) — Selling General And Administration: 17732000.00
BCAB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3260000.00
BCAB balance_sheet (annual, 2025-12-31) — Share Issued: 1269286.00
BCAB balance_sheet (quarterly, 2025-12-31) — Share Issued: 1269286.00
BCAB cash_flow (annual, 2025-12-31) — Stock Based Compensation: 5434000.00
BCAB cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1120000.00
BCAB balance_sheet (annual, 2025-12-31) — Stockholders Equity: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -36189000.00
BCAB balance_sheet (annual, 2025-12-31) — Tangible Book Value: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -36189000.00
BCAB income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BCAB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BCAB income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BCAB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BCAB balance_sheet (annual, 2025-12-31) — Total Assets: 13828000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Assets: 13828000.00
BCAB balance_sheet (annual, 2025-12-31) — Total Capitalization: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -36189000.00
BCAB balance_sheet (annual, 2025-12-31) — Total Debt: 6200000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Debt: 6200000.00
BCAB balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -36189000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -36189000.00
BCAB income_statement (annual, 2025-12-31) — Total Expenses: 61305000.00
BCAB income_statement (quarterly, 2025-12-31) — Total Expenses: 11255000.00
BCAB balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 50017000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 50017000.00
BCAB balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 5815000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 5815000.00
BCAB balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 28095000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 28095000.00
BCAB income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -59305000.00
BCAB income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -9255000.00
BCAB income_statement (annual, 2025-12-31) — Total Unusual Items: 295000.00
BCAB income_statement (quarterly, 2025-12-31) — Total Unusual Items: 831000.00
BCAB income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 295000.00
BCAB income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 831000.00
BCAB cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 406000.00
BCAB balance_sheet (annual, 2025-12-31) — Working Capital: -13909000.00
BCAB balance_sheet (quarterly, 2025-12-31) — Working Capital: -13909000.00
BCAB income_statement (quarterly, 2026-03-31) — +Operating Expense: 9308000.00
BCAB income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 12123000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -5428000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 514681000.00
BCAB income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1501649.00
BCAB income_statement (quarterly, 2026-03-31) — Basic EPS: -4.22
BCAB cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 7118000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 6094000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1961000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1961000.00
BCAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 110000.00
BCAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -5267000.00
BCAB cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 3069000.00
BCAB cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 116000.00
BCAB cash_flow (quarterly, 2026-03-31) — Change In Payable: 3069000.00
BCAB cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3069000.00
BCAB cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -237000.00
BCAB cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2948000.00
BCAB cash_flow (quarterly, 2026-03-31) — Changes In Cash: -5157000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -37309000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 7010000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Current Assets: 3093000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1559000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1559000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 20692000.00
BCAB cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 120000.00
BCAB cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 120000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 842000.00
BCAB income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1501649.00
BCAB income_statement (quarterly, 2026-03-31) — Diluted EPS: -4.22
BCAB income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — EBIT: -9308000.00
BCAB income_statement (quarterly, 2026-03-31) — EBITDA: -9188000.00
BCAB cash_flow (quarterly, 2026-03-31) — End Cash Position: 1961000.00
BCAB cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 110000.00
BCAB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5267000.00
BCAB cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -2674000.00
BCAB income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 2674000.00
BCAB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4726000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Gross PPE: 10738000.00
BCAB income_statement (quarterly, 2026-03-31) — Interest Income: 37000.00
BCAB income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 37000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Invested Capital: -37309000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Leases: 2498000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 4535000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4535000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1101000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Income: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -6344000.00
BCAB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -6344000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Interest Income: 37000.00
BCAB income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 37000.00
BCAB cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -303000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Net PPE: 5310000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -37309000.00
BCAB income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -11862000.00
BCAB income_statement (quarterly, 2026-03-31) — Normalized Income: -9018000.00
BCAB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -5267000.00
BCAB cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2674000.00
BCAB income_statement (quarterly, 2026-03-31) — Operating Income: -9308000.00
BCAB income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1659612.00
BCAB balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 126000.00
BCAB income_statement (quarterly, 2026-03-31) — Other Gand A: 4726000.00
BCAB income_statement (quarterly, 2026-03-31) — Other Income Expense: 2927000.00
BCAB cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -273000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 163000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 19806000.00
BCAB income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 253000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Other Properties: 7139000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Payables: 12123000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 19133000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1006000.00
BCAB income_statement (quarterly, 2026-03-31) — Pretax Income: -6344000.00
BCAB cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 413000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
BCAB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 120000.00
BCAB income_statement (quarterly, 2026-03-31) — Research And Development: 4582000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -551990000.00
BCAB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4726000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Share Issued: 1659612.00
BCAB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 956000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -37309000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -37309000.00
BCAB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BCAB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Assets: 8566000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -37309000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Debt: 6094000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -37309000.00
BCAB income_statement (quarterly, 2026-03-31) — Total Expenses: 9308000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 45875000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5473000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 25183000.00
BCAB income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -9308000.00
BCAB income_statement (quarterly, 2026-03-31) — Total Unusual Items: 2674000.00
BCAB income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 2674000.00
BCAB balance_sheet (quarterly, 2026-03-31) — Working Capital: -17599000.00
BCAL balance_sheet (annual, 2021-12-31) — Cash Financial: 22435000.00
BCAL cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
BCAL cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -46000.00
BCAL cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -726000.00
BCAL income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 726000.00
BCAL income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 46000.00
BCAL cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
BCAL cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
BCAL cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
BCAL cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -10187000.00
BCAL income_statement (annual, 2021-12-31) — Other Special Charges: 4000.00
BCAL cash_flow (annual, 2021-12-31) — Purchase Of Business: -81467000.00
BCAL cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
BCAL income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 678000.00
BCAL income_statement (annual, 2022-12-31) — +Total Revenue: 92229000.00
BCAL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -7045000.00
BCAL income_statement (annual, 2022-12-31) — Amortization: 438000.00
BCAL cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 438000.00
BCAL cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 438000.00
BCAL income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 438000.00
BCAL cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 136000.00
BCAL income_statement (annual, 2022-12-31) — Basic Average Shares: 17821545.00
BCAL income_statement (annual, 2022-12-31) — Basic EPS: 0.90
BCAL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 580006000.00
BCAL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4766000.00
BCAL cash_flow (annual, 2022-12-31) — Capital Expenditure: -1081000.00
BCAL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 11055000.00
BCAL balance_sheet (annual, 2022-12-31) — Capital Stock: 218280000.00
BCAL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 60295000.00
BCAL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 101303000.00
BCAL balance_sheet (annual, 2022-12-31) — Cash Financial: 60295000.00
BCAL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 6098000.00
BCAL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -512696000.00
BCAL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 13352000.00
BCAL cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2051000.00
BCAL cash_flow (annual, 2022-12-31) — Change In Working Capital: -2051000.00
BCAL cash_flow (annual, 2022-12-31) — Changes In Cash: -493246000.00
BCAL balance_sheet (annual, 2022-12-31) — Common Stock: 218280000.00
BCAL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 260355000.00
BCAL cash_flow (annual, 2022-12-31) — Common Stock Payments: -574000.00
BCAL cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2550000.00
BCAL cash_flow (annual, 2022-12-31) — Deferred Tax: -2550000.00
BCAL cash_flow (annual, 2022-12-31) — Depreciation: 1563000.00
BCAL cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2001000.00
BCAL income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 438000.00
BCAL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2001000.00
BCAL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 438000.00
BCAL income_statement (annual, 2022-12-31) — Diluted Average Shares: 18228287.00
BCAL income_statement (annual, 2022-12-31) — Diluted EPS: 0.88
BCAL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 16113000.00
BCAL cash_flow (annual, 2022-12-31) — End Cash Position: 86760000.00
BCAL cash_flow (annual, 2022-12-31) — Financing Cash Flow: 6098000.00
BCAL cash_flow (annual, 2022-12-31) — Free Cash Flow: 12271000.00
BCAL cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 994000.00
BCAL cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
BCAL cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 768000.00
BCAL income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
BCAL income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -994000.00
BCAL balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6441000.00
BCAL income_statement (annual, 2022-12-31) — General And Administrative Expense: 38015000.00
BCAL balance_sheet (annual, 2022-12-31) — Goodwill: 37803000.00
BCAL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 39387000.00
BCAL balance_sheet (annual, 2022-12-31) — Gross PPE: 29986000.00
BCAL balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 53946000.00
BCAL cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 7954000.00
BCAL income_statement (annual, 2022-12-31) — Interest Expense: 5789000.00
BCAL income_statement (annual, 2022-12-31) — Interest Income: 93575000.00
BCAL cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 5552000.00
BCAL balance_sheet (annual, 2022-12-31) — Invested Capital: 328125000.00
BCAL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -512696000.00
BCAL balance_sheet (annual, 2022-12-31) — Investments And Advances: 166526000.00
BCAL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 50000000.00
BCAL balance_sheet (annual, 2022-12-31) — Land And Improvements: 5386000.00
BCAL balance_sheet (annual, 2022-12-31) — Leases: 5351000.00
BCAL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 11055000.00
BCAL balance_sheet (annual, 2022-12-31) — Long Term Debt: 67770000.00
BCAL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 78825000.00
BCAL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 50000000.00
BCAL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3093000.00
BCAL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5876000.00
BCAL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
BCAL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -574000.00
BCAL balance_sheet (annual, 2022-12-31) — Net Debt: 7475000.00
BCAL income_statement (annual, 2022-12-31) — Net Income: 16113000.00
BCAL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 16113000.00
BCAL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 16113000.00
BCAL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 16113000.00
BCAL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 16113000.00
BCAL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 16113000.00
BCAL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 16113000.00
BCAL income_statement (annual, 2022-12-31) — Net Interest Income: 87786000.00
BCAL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -126656000.00
BCAL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 46907000.00
BCAL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 46907000.00
BCAL cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1366000.00
BCAL balance_sheet (annual, 2022-12-31) — Net PPE: 22941000.00
BCAL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 2830000.00
BCAL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 220968000.00
BCAL income_statement (annual, 2022-12-31) — Normalized Income: 21588510.00
BCAL income_statement (annual, 2022-12-31) — Occupancy And Equipment: 6210000.00
BCAL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 13352000.00
BCAL cash_flow (annual, 2022-12-31) — Operating Gains Losses: 760000.00
BCAL income_statement (annual, 2022-12-31) — Operating Revenue: 92229000.00
BCAL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 17940283.00
BCAL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6441000.00
BCAL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1584000.00
BCAL cash_flow (annual, 2022-12-31) — Other Non Cash Items: -7725000.00
BCAL income_statement (annual, 2022-12-31) — Other Non Interest Expense: 9560000.00
BCAL balance_sheet (annual, 2022-12-31) — Other Properties: 8607000.00
BCAL balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 112580000.00
BCAL income_statement (annual, 2022-12-31) — Other Special Charges: 6293000.00
BCAL balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
BCAL income_statement (annual, 2022-12-31) — Pretax Income: 21983000.00
BCAL cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1009000.00
BCAL income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 2597000.00
BCAL cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
BCAL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -160369000.00
BCAL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1081000.00
BCAL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2001000.00
BCAL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3093000.00
BCAL cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -574000.00
BCAL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 1177000.00
BCAL balance_sheet (annual, 2022-12-31) — Retained Earnings: 48516000.00
BCAL income_statement (annual, 2022-12-31) — Salaries And Wages: 38015000.00
BCAL cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
BCAL cash_flow (annual, 2022-12-31) — Sale Of Investment: 33713000.00
BCAL cash_flow (annual, 2022-12-31) — Sale Of PPE: 3911000.00
BCAL income_statement (annual, 2022-12-31) — Selling General And Administration: 38015000.00
BCAL balance_sheet (annual, 2022-12-31) — Share Issued: 17940283.00
BCAL income_statement (annual, 2022-12-31) — Special Income Charges: -7470000.00
BCAL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3682000.00
BCAL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 260355000.00
BCAL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 220968000.00
BCAL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1994490.00
BCAL income_statement (annual, 2022-12-31) — Tax Provision: 5870000.00
BCAL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.27
BCAL balance_sheet (annual, 2022-12-31) — Total Assets: 2283927000.00
BCAL balance_sheet (annual, 2022-12-31) — Total Capitalization: 328125000.00
BCAL balance_sheet (annual, 2022-12-31) — Total Debt: 78825000.00
BCAL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 260355000.00
BCAL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2023572000.00
BCAL income_statement (annual, 2022-12-31) — Total Unusual Items: -7470000.00
BCAL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -7470000.00
BCAL income_statement (annual, 2023-12-31) — +Total Revenue: 97517000.00
BCAL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -8575000.00
BCAL income_statement (annual, 2023-12-31) — Amortization: 389000.00
BCAL cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 389000.00
BCAL cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 389000.00
BCAL income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 389000.00
BCAL cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 134000.00
BCAL income_statement (annual, 2023-12-31) — Basic Average Shares: 18246479.00
BCAL income_statement (annual, 2023-12-31) — Basic EPS: 1.42
BCAL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 86760000.00
BCAL balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4766000.00
BCAL cash_flow (annual, 2023-12-31) — Capital Expenditure: -302000.00
BCAL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 12117000.00
BCAL balance_sheet (annual, 2023-12-31) — Capital Stock: 222036000.00
BCAL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 33008000.00
BCAL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 102848000.00
BCAL balance_sheet (annual, 2023-12-31) — Cash Financial: 33008000.00
BCAL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 45858000.00
BCAL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -78927000.00
BCAL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 33102000.00
BCAL cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1790000.00
BCAL cash_flow (annual, 2023-12-31) — Change In Working Capital: -1790000.00
BCAL cash_flow (annual, 2023-12-31) — Changes In Cash: 33000.00
BCAL balance_sheet (annual, 2023-12-31) — Common Stock: 222036000.00
BCAL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 288152000.00
BCAL cash_flow (annual, 2023-12-31) — Common Stock Payments: -889000.00
BCAL cash_flow (annual, 2023-12-31) — Deferred Income Tax: 418000.00
BCAL cash_flow (annual, 2023-12-31) — Deferred Tax: 418000.00
BCAL cash_flow (annual, 2023-12-31) — Depreciation: 1530000.00
BCAL cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1919000.00
BCAL income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 389000.00
BCAL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1919000.00
BCAL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 389000.00
BCAL income_statement (annual, 2023-12-31) — Diluted Average Shares: 18656742.00
BCAL income_statement (annual, 2023-12-31) — Diluted EPS: 1.39
BCAL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 25910000.00
BCAL cash_flow (annual, 2023-12-31) — End Cash Position: 86793000.00
BCAL cash_flow (annual, 2023-12-31) — Financing Cash Flow: 45858000.00
BCAL cash_flow (annual, 2023-12-31) — Free Cash Flow: 32800000.00
BCAL cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 974000.00
BCAL cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
BCAL income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -974000.00
BCAL balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -4459000.00
BCAL income_statement (annual, 2023-12-31) — General And Administrative Expense: 40098000.00
BCAL balance_sheet (annual, 2023-12-31) — Goodwill: 37803000.00
BCAL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 38998000.00
BCAL balance_sheet (annual, 2023-12-31) — Gross PPE: 31136000.00
BCAL balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 53616000.00
BCAL cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 12373000.00
BCAL income_statement (annual, 2023-12-31) — Interest Expense: 29384000.00
BCAL income_statement (annual, 2023-12-31) — Interest Income: 123522000.00
BCAL cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 29027000.00
BCAL balance_sheet (annual, 2023-12-31) — Invested Capital: 391017000.00
BCAL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -78927000.00
BCAL balance_sheet (annual, 2023-12-31) — Investments And Advances: 183651000.00
BCAL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 92000000.00
BCAL balance_sheet (annual, 2023-12-31) — Land And Improvements: 5386000.00
BCAL balance_sheet (annual, 2023-12-31) — Leases: 5584000.00
BCAL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 12117000.00
BCAL balance_sheet (annual, 2023-12-31) — Long Term Debt: 102865000.00
BCAL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 114982000.00
BCAL cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 92000000.00
BCAL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -57000000.00
BCAL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 6109000.00
BCAL cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
BCAL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -889000.00
BCAL balance_sheet (annual, 2023-12-31) — Net Debt: 69857000.00
BCAL income_statement (annual, 2023-12-31) — Net Income: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 25910000.00
BCAL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Net Interest Income: 94138000.00
BCAL cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -19341000.00
BCAL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 35000000.00
BCAL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 35000000.00
BCAL balance_sheet (annual, 2023-12-31) — Net PPE: 22561000.00
BCAL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -302000.00
BCAL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 249154000.00
BCAL income_statement (annual, 2023-12-31) — Normalized Income: 25910000.00
BCAL income_statement (annual, 2023-12-31) — Occupancy And Equipment: 6231000.00